Medicare Costs for Prostate Screenings for Men 75+ May Outweigh Benefits

According to a study published by researchers at Yale, prostate cancer screenings for men 75 and older were shown to have little benefit, in spite of accounting for 1/3 of the money spent annually on such screenings. The study, which followed older male Medicare beneficiaries for three years, also found that geographical location played a large role in determining cost. However, it is not clear that this increase in cost effectively reduces the rate of metastatic cancers. More here

Leave a Reply

Your email address will not be published. Required fields are marked *